Kidney failure, also known as end-stage kidney disease, is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible. Symptoms may include leg swelling, feeling tired, vomiting, loss of appetite, and confusion. Complications of acute and chronic failure include uremia, hyperkalaemia, and volume overload. Complications of chronic failure also include heart disease, high blood pressure, and anaemia.
|Other names||Renal failure, end-stage renal disease (ESRD), stage 5 chronic kidney disease|
|A hemodialysis machine which is used to replace the function of the kidneys|
|Symptoms||Leg swelling, feeling tired, loss of appetite, confusion|
|Complications||Acute: Uremia, high blood potassium, volume overload|
Chronic: Heart disease, high blood pressure, anemia
|Types||Acute kidney failure, chronic kidney failure|
|Diagnostic method||Acute: |
|Treatment||Acute: Depends on the cause|
Chronic: Hemodialysis, peritoneal dialysis, kidney transplant
|Frequency||Acute: 3 per 1,000 per year|
Chronic: 1 per 1,000 (US)
Causes of acute kidney failure include low blood pressure, blockage of the urinary tract, certain medications, muscle breakdown, and hemolytic uremic syndrome. Causes of chronic kidney failure include diabetes, high blood pressure, nephrotic syndrome, and polycystic kidney disease. Diagnosis of acute failure is often based on a combination of factors such as decreased urine production or increased serum creatinine. Diagnosis of chronic failure is based on a glomerular filtration rate (GFR) of less than 15 or the need for renal replacement therapy. It is also equivalent to stage 5 chronic kidney disease.
Treatment of acute failure depends on the underlying cause. Treatment of chronic failure may include hemodialysis, peritoneal dialysis, or a kidney transplant. Hemodialysis uses a machine to filter the blood outside the body. In peritoneal dialysis specific fluid is placed into the abdominal cavity and then drained, with this process being repeated multiple times per day. Kidney transplantation involves surgically placing a kidney from someone else and then taking immunosuppressant medication to prevent rejection. Other recommended measures from chronic disease include staying active and specific dietary changes. Depression is also common among patients with kidney failure, and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. A recent PCORI-funded study of patients with kidney failure receiving outpatient hemodialysis found similar effectiveness between nonpharmacological and pharmacological treatments for depression.
In the United States, acute failure affects about 3 per 1,000 people a year. Chronic failure affects about 1 in 1,000 people with 3 per 10,000 people newly developing the condition each year. Acute failure is often reversible while chronic failure often is not. With appropriate treatment many with chronic disease can continue working.
Kidney failure can be divided into two categories: acute kidney failure or chronic kidney failure. The type of renal failure is differentiated by the trend in the serum creatinine; other factors that may help differentiate acute kidney failure from chronic kidney failure include anemia and the kidney size on sonography as chronic kidney disease generally leads to anemia and small kidney size.
Acute kidney failure edit
Acute kidney injury (AKI), previously called acute renal failure (ARF), is a rapidly progressive loss of renal function, generally characterized by oliguria (decreased urine production, quantified as less than 400 mL per day in adults, less than 0.5 mL/kg/h in children or less than 1 mL/kg/h in infants); and fluid and electrolyte imbalance. AKI can result from a variety of causes, generally classified as prerenal, intrinsic, and postrenal. Many people diagnosed with paraquat intoxication experience AKI, sometimes requiring hemodialysis. The underlying cause must be identified and treated to arrest the progress, and dialysis may be necessary to bridge the time gap required for treating these fundamental causes.
Chronic kidney failure edit
Chronic kidney disease (CKD) can also develop slowly and, initially, show few symptoms. CKD can be the long term consequence of irreversible acute disease or part of a disease progression. CKD is divided into 5 different stages (1-5) according to the estimated glomerular filtration rate (eGFR). In CKD1 eGFR is normal and in CKD5 eGFR has decreased to less than 15 ml/min.
Acute-on-chronic kidney failure edit
Acute kidney injuries can be present on top of chronic kidney disease, a condition called acute-on-chronic kidney failure (AoCRF). The acute part of AoCRF may be reversible, and the goal of treatment, as with AKI, is to return the person to baseline kidney function, typically measured by serum creatinine. Like AKI, AoCRF can be difficult to distinguish from chronic kidney disease if the person has not been monitored by a physician and no baseline (i.e., past) blood work is available for comparison.
Signs and symptoms edit
Symptoms can vary from person to person. Someone in early stage kidney disease may not feel sick or notice symptoms as they occur. When the kidneys fail to filter properly, waste accumulates in the blood and the body, a condition called azotemia. Very low levels of azotaemia may produce few, if any, symptoms. If the disease progresses, symptoms become noticeable (if the failure is of sufficient degree to cause symptoms). Kidney failure accompanied by noticeable symptoms is termed uraemia.
- High levels of urea in the blood, which can result in:
- Vomiting or diarrhea (or both) that may lead to dehydration
- Weight loss
- Nocturnal urination (nocturia)
- More frequent urination, or in greater amounts than usual, with pale urine
- Less frequent urination, or in smaller amounts than usual, with dark coloured urine
- Blood in the urine
- Pressure, or difficulty urinating
- Unusual amounts of urination, usually in large quantities
- A buildup of phosphates in the blood that diseased kidneys cannot filter out may cause:
- A buildup of potassium in the blood that diseased kidneys cannot filter out (called hyperkalemia) may cause:
- Abnormal heart rhythms
- Muscle paralysis
- Failure of kidneys to remove excess fluid may cause:
- Swelling of the hands, legs, ankles, feet, or face
- Shortness of breath due to extra fluid on the lungs (may also be caused by anemia)
- Polycystic kidney disease, which causes large, fluid-filled cysts on the kidneys and sometimes the liver, can cause:
- Pain in the back or side
- Healthy kidneys produce the hormone erythropoietin that stimulates the bone marrow to make oxygen-carrying red blood cells. As the kidneys fail, they produce less erythropoietin, resulting in decreased production of red blood cells to replace the natural breakdown of old red blood cells. As a result, the blood carries less hemoglobin, a condition known as anemia. This can result in:
- Feeling tired or weak
- Memory problems
- Difficulty concentrating
- Low blood pressure
- Normally proteins are too large to pass through the kidneys. However they are able to pass through when the glomeruli are damaged. This does not cause symptoms until extensive kidney damage has occurred, after which symptoms include:
- Foamy or bubbly urine
- Swelling in the hands, feet, abdomen, and face
- Other symptoms include:
Acute kidney injury edit
Acute kidney injury (previously known as acute renal failure) – or AKI – usually occurs when the blood supply to the kidneys is suddenly interrupted or when the kidneys become overloaded with toxins. Causes of acute kidney injury include accidents, injuries, or complications from surgeries in which the kidneys are deprived of normal blood flow for extended periods of time. Heart-bypass surgery is an example of one such procedure.
Drug overdoses, accidental or from chemical overloads of drugs such as antibiotics or chemotherapy, along with bee stings may also cause the onset of acute kidney injury. Unlike chronic kidney disease, however, the kidneys can often recover from acute kidney injury, allowing the person with AKI to resume a normal life. People with acute kidney injury require supportive treatment until their kidneys recover function, and they often remain at increased risk of developing future kidney failure.
Among the accidental causes of renal failure is the crush syndrome, when large amounts of toxins are suddenly released in the blood circulation after a long compressed limb is suddenly relieved from the pressure obstructing the blood flow through its tissues, causing ischemia. The resulting overload can lead to the clogging and the destruction of the kidneys. It is a reperfusion injury that appears after the release of the crushing pressure. The mechanism is believed to be the release into the bloodstream of muscle breakdown products – notably myoglobin, potassium, and phosphorus – that are the products of rhabdomyolysis (the breakdown of skeletal muscle damaged by ischemic conditions). The specific action on the kidneys is not fully understood, but may be due in part to nephrotoxic metabolites of myoglobin.
Chronic kidney failure edit
Chronic kidney failure has numerous causes. The most common causes of chronic failure are diabetes mellitus and long-term, uncontrolled hypertension. Polycystic kidney disease is another well-known cause of chronic failure. The majority of people affected with polycystic kidney disease have a family history of the disease. Systemic lupus erythematosus (SLE) is also a known cause of chronic kidney failure. Other genetic illnesses cause kidney failure, as well.
Genetic predisposition edit
The APOL1 gene has been proposed as a major genetic risk locus for a spectrum of nondiabetic renal failure in individuals of African origin, these include HIV-associated nephropathy (HIVAN), primary nonmonogenic forms of focal segmental glomerulosclerosis, and hypertension affiliated chronic kidney disease not attributed to other etiologies. Two western African variants in APOL1 have been shown to be associated with end stage kidney disease in African Americans and Hispanic Americans.
Diagnostic approach edit
Measurement for CKD edit
- Stages of kidney failure
Chronic kidney failure is measured in five stages, which are calculated using the person's GFR, or glomerular filtration rate. Stage 1 CKD is mildly diminished renal function, with few overt symptoms. Stages 2 and 3 need increasing levels of supportive care from their medical providers to slow and treat their renal dysfunction. People with stage 4 and 5 kidney failure usually require preparation towards active treatment in order to survive. Stage 5 CKD is considered a severe illness and requires some form of renal replacement therapy (dialysis) or kidney transplant whenever feasible.
- Glomerular filtration rate
A normal GFR varies according to many factors, including sex, age, body size and ethnic background. Renal professionals consider the glomerular filtration rate (GFR) to be the best overall index of kidney function. The National Kidney Foundation offers an easy to use on-line GFR calculator for anyone who is interested in knowing their glomerular filtration rate. (A serum creatinine level, a simple blood test, is needed to use the calculator.)
Use of the term uremia edit
Before the advancement of modern medicine, renal failure was often referred to as uremic poisoning. Uremia was the term for the contamination of the blood with urea. It is the presence of an excessive amount of urea in blood. Starting around 1847, this included reduced urine output, which was thought to be caused by the urine mixing with the blood instead of being voided through the urethra. The term uremia is now used for the illness accompanying kidney failure.
Those with end stage renal failure who undergo haemodialysis have higher risk of spontaneous intra-abdominal bleeding than the general population (21.2%) and non-occlusive mesenteric ischemia (18.1%). Meanwhile, those undergoing peritoneal dialysis have a higher chance of developing peritonitis and gastrointestinal perforation. However, the rate of acute pancreatitis does not differ from the general population.
The treatment of acute kidney injury depends on the cause. The treatment of chronic kidney failure may include renal replacement therapy: hemodialysis, peritoneal dialysis, or kidney transplant.
In non-diabetics and people with type 1 diabetes, a low protein diet is found to have a preventive effect on progression of chronic kidney disease. However, this effect does not apply to people with type 2 diabetes. A whole food, plant-based diet may help some people with kidney disease. A high protein diet from either animal or plant sources appears to have negative effects on kidney function at least in the short term.
Slowing progression edit
People who receive earlier referrals to a nephrology specialist, meaning a longer time before they must start dialysis, have a shorter initial hospitalization and reduced risk of death after the start of dialysis. Other methods of reducing disease progression include minimizing exposure to nephrotoxins such as NSAIDs and intravenous contrast.
- Cheung AK (2005). Primer on Kidney Diseases. Elsevier Health Sciences. p. 457. ISBN 1416023127.
- "Kidney Failure". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 11 November 2017.
- Blakeley S (2010). Renal Failure and Replacement Therapies. Springer Science & Business Media. p. 19. ISBN 9781846289378.
- Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC (2012). "Insulin resistance in patients with chronic kidney disease". Journal of Biomedicine & Biotechnology. 2012: 691369. doi:10.1155/2012/691369. PMC 3420350. PMID 22919275.
- "Kidney Failure". MedlinePlus. Retrieved 11 November 2017.
- "What is renal failure?". Johns Hopkins Medicine. Archived from the original on 18 June 2017. Retrieved 18 December 2017.
- Clatworthy M (2010). Nephrology: Clinical Cases Uncovered. John Wiley & Sons. p. 28. ISBN 9781405189903.
- Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 37. ISBN 9780323529570.
- Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, et al. (March 2019). "Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial". Annals of Internal Medicine. 170 (6): 369–379. doi:10.7326/M18-2229. PMID 30802897. S2CID 67876948.
- Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 294. ISBN 9780323529570.
- Moore EM, Bellomo R, Nichol AD (November 2012). "The meaning of acute kidney injury and its relevance to intensive care and anaesthesia". Anaesthesia and Intensive Care. 40 (6): 929–48. doi:10.1177/0310057X1204000604. PMID 23194202.
- Ricci Z, Ronco C (2012). "New insights in acute kidney failure in the critically ill". Swiss Medical Weekly. 142: w13662. doi:10.4414/smw.2012.13662. PMID 22923149.
- "Acute kidney failure". A.D.A.M. Medical Encyclopedia. U.S. National Library of Medicine. 2012. Archived from the original on 17 January 2014. Retrieved 1 January 2013.
- Klahr S, Miller SB (March 1998). "Acute oliguria". The New England Journal of Medicine. 338 (10): 671–5. doi:10.1056/NEJM199803053381007. PMID 9486997.
- "Chronic kidney disease". A.D.A.M. Medical Encyclopedia. Medline Plus, National Institutes of Health. 2011. Retrieved 1 January 2013.
- "Stages of kidney disease". www.kidneyfund.org. 2021-11-22. Retrieved 2023-03-09.
- Grinsted P (2005-03-02). "Kidney failure (renal failure with uremia, or azotaemia)". Retrieved 2009-05-26.
- Stein A (2007-07-01). Understanding Treatment Options For Renal Therapy. Deerfield, Illinois: Baxter International Inc. p. 6. ISBN 978-1-85959-070-6. Archived from the original on 2019-01-30. Retrieved 2010-07-12.
- The PD Companion. Deerfield, Illinois: Baxter International Inc. 2008-05-01. pp. 14–15. 08/1046R. Archived from the original on 2010-06-25. Retrieved 2010-07-12.
- Amgen Inc. (2009). "10 Symptoms of Kidney Disease". Retrieved 2009-05-26.
- "Hyperkalemia". MedicineNet, Inc. 2008-07-03. Retrieved 2009-05-26.
- Hebert LA, Charleston J, Miller E (2009). "Proteinuria". Archived from the original on 2011-05-05. Retrieved 2011-03-24.
- Katzung BG (2007). Basic and Clinical Pharmacology (10th ed.). New York, NY: McGraw Hill Medical. p. 733. ISBN 978-0-07-145153-6.
- Silva GB, Vasconcelos AG, Rocha AM, Vasconcelos VR, Barros J, Fujishima JS, et al. (June 2017). "Acute kidney injury complicating bee stings - a review". Revista do Instituto de Medicina Tropical de Sao Paulo. 59: e25. doi:10.1590/S1678-9946201759025. PMC 5459532. PMID 28591253.
- National Kidney and Urologic Diseases Information Clearinghouse (2012). "The Kidneys and How They Work". National Institute of Diabetes and Digestive and Kidney Diseases. Archived from the original on 2 May 2015. Retrieved 1 January 2013.
- Kes P, Basić-Jukić N, Ljutić D, Brunetta-Gavranić B (October 2011). "[The role of arterial hypertension in development of chronic renal failure]" [The role of arterial hypertension in the development of chronic renal failure] (PDF). Acta Medica Croatica (in Croatian). 65 (Suppl 3): 78–84. PMID 23120821. Archived from the original (PDF) on 2013-07-19.
- Perneger TV, Whelton PK, Klag MJ (December 1994). "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs". The New England Journal of Medicine. 331 (25): 1675–9. doi:10.1056/NEJM199412223312502. PMID 7969358.
- Appel GB, Mustonen J (2012). "Renal involvement with hantavirus infection (hemorrhagic fever with renal syndrome)". UpToDate. Retrieved 1 January 2013.
- Bostrom MA, Freedman BI (June 2010). "The spectrum of MYH9-associated nephropathy". Clinical Journal of the American Society of Nephrology. 5 (6): 1107–13. doi:10.2215/CJN.08721209. PMC 4890964. PMID 20299374.
- Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (August 2010). "Association of trypanolytic ApoL1 variants with kidney disease in African Americans". Science. 329 (5993): 841–5. Bibcode:2010Sci...329..841G. doi:10.1126/science.1193032. PMC 2980843. PMID 20647424.
- Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. (September 2010). "Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene". Human Genetics. 128 (3): 345–50. doi:10.1007/s00439-010-0861-0. PMC 2921485. PMID 20635188.
- Fadem, Stephen Z., M.D., FACP, FASN. Calculators for HealthCare Professionals. National Kidney Foundation. 13 Oct 2008
- "GFR calculator". Kidney.org. Retrieved 2011-09-25.
- Meyer TW, Hostetter TH (September 2007). "Uremia". The New England Journal of Medicine. 357 (13): 1316–25. doi:10.1056/NEJMra071313. PMID 17898101.
- Tonolini M, Ierardi AM, Carrafiello G (December 2015). "Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease". Insights into Imaging. 6 (6): 693–695. doi:10.1007/s13244-015-0439-4. PMC 4656237. PMID 26472545.
- Rughooputh MS, Zeng R, Yao Y (28 December 2015). "Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate". PLOS ONE. 10 (12): e0145505. Bibcode:2015PLoSO..1045505R. doi:10.1371/journal.pone.0145505. PMC 4692386. PMID 26710078.
- Chauveau P, Combe C, Fouque D, Aparicio M (November 2013). "Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases". Journal of Renal Nutrition. 23 (6): 399–405. doi:10.1053/j.jrn.2013.08.004. PMID 24070587.
- Bernstein AM, Treyzon L, Li Z (April 2007). "Are high-protein, vegetable-based diets safe for kidney function? A review of the literature". Journal of the American Dietetic Association. 107 (4): 644–50. doi:10.1016/j.jada.2007.01.002. PMID 17383270. S2CID 39551628.
- Smart NA, Dieberg G, Ladhani M, Titus T (June 2014). "Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease". The Cochrane Database of Systematic Reviews (6): CD007333. doi:10.1002/14651858.CD007333.pub2. PMID 24938824.
- Dirkx TC, Woodell T, Watnick S (2017). Papadakis MA, McPhee SJ, Rabow MW (eds.). Current Medical Diagnosis & Treatment 2018. New York, NY: McGraw-Hill Education.